晚期NSCLC,advanced NSCLC
1)advanced NSCLC晚期NSCLC
1.Methods:Eight possible influencing factors were analyzed,data of the 76 post-chemotherapeutic acquired pneumonia ofadvanced NSCLC from June to June was conducted.方法:选择8个可能对化疗后获得性肺炎产生影响的研究因素,进行Logistic回归分析,对我院6月～6月期间收治的76例晚期NSCLC化疗后获得性肺炎患者进行研究。
英文短句/例句
1.Influence of age and comorbidity on survival of patients with advanced non-small-cell lung cancer两种因素对晚期NSCLC患者预后的影响
2.Effect of Irinotecan Combined with Radiotherapy in Patients with Advanced Non-small Cell Lung Cancer伊立替康联合放疗治疗晚期NSCLC的疗效
3.Clinical Experience of Treating Senile Advanced Non-small Cell Lung Cancer by Erlotinib厄洛替尼治疗老年晚期NSCLC的临床观察
4.Clinical Significance of Tumor Markers in Patients with Advanced Non-small Cell Lung Cancer;肿瘤标志物在晚期NSCLC诊治中的临床意义和价值
5.Observational study on the effects of treating advanced NSCLC usingTP chemotherapy and microwave thermotherapy微波热疗联合化疗治疗晚期NSCLC疗效观察
bination of Shenmei injection and GP chemotherapy for treatmen of advanced non-small cell lung cancerGP方案联合参麦注射液治疗晚期NSCLC临床观察
7.Disease control rate and survival in advanced non-small cell lung cancer after first-line chemotherapy晚期NSCLC一线化疗疾病控制与生存关系的分析
8.Rh-endostatin in Combination with Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer重组人内皮抑素联合化疗治疗晚期NSCLC近期疗效观察
9.Analysis of short-term effects using accelerated-hypofractiovated three dimensional conformal radiotherapy for late-course NSCLC三维适形后程逐步递量加速放疗局部晚期NSCLC的近期疗效观察
10.Significance of Serum VEGF in Lung Cancer and Angiogenic Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer;VEGF在肺癌中的临床意义及抗血管生成药物二线治疗晚期NSCLC
11.The Clinical Observation of the Application of Jianpi Yishen Buqi Yangxue Method Treating Tumor Anemia of Xuexu Type for Advanced-Stage Nsclc Patients健脾益肾补气养血法治疗晚期NSCLC患者血虚型癌性贫血的临床观察
12.Investigation about Expression of RRM1 (Ribonucleo-tide Reductase M1) and the Correlation with Gemcita-bine-based Chemotherapy Sensitivity in the Advanced Non-small Cell Lung Cancer晚期NSCLC组织RRM1的表达及与吉西他滨化疗敏感性的研究
13.Pooled Analysis of the Trials of Erlotinib Monotherapy for Epidermal Growth Factor Receptor (EGFR)-mutant Advanced Non-small Cell Lung Cancer厄洛替尼单药治疗EGFR突变的晚期NSCLC患者试验汇合分析
14.Efficacy of endostar combined with vinorelbine and cisplatin in treatment of advanced non-small-cell lung cancer重组人血管内皮抑素联合NP方案治疗晚期NSCLC的临床疗效观察
15.Gemcitabine Combined with Kanglaite Injection in Treatment for 30 Cases with Elderly Advanced Non-small Cell Lung Cancer吉西他滨联合康莱特注射液治疗30例老年晚期NSCLC
16.A randomized trial comparing oxaliplatin plus docetaxel versus oxaliplatin Plus vinorelbine for the treatmen for elder patients with advanced non-small cell lung cancer奥沙利铂加多西紫杉醇与奥沙利铂加长春瑞宾治疗43例老年晚期NSCLC的对照研究
17.Epidermal Growth Factor Receptor Gene Mutation and the Molecular Target Therapy of Late Period Non-small-cell Lung CancerEGFR基因突变与晚期非小细胞肺癌（NSCLC）的分子靶向治疗
18.Vascular Endothelial Growth Factor Expression in Stage I_A Non-Small Cell Lung Cancer and Clinical Significance;VEGF在I_A期NSCLC中的表达和临床意义
相关短句/例句
NSCLCⅢ期NSCLC
1.Efficacy of Yan-shu injection combined with concurrent chemoradiotherapy for 45 unresectable stage ⅢNSCLC patients;岩舒注射液联合放化疗治疗不可手术Ⅲ期NSCLC 45例临床观察
3)Ⅲa stage NSCLCⅢa期NSCLC
4)Advanced stage NSCLC老年晚期非小细胞肺癌患者(advanced stage NSCLC)
5)advanced[英][?d"vɑ:nst][美][?d"v?nst]晚期
1.Analysis of chemotherapy with 5-FU by continous intravenous infusion and cisplatin in head and neckadvanced cancer;持续静脉滴注氟尿嘧啶联合顺铂治疗晚期头颈部癌
2.The evaluations ofadvanced non-small cell lung cancer patients treated with erlotnib;厄洛替尼治疗复治晚期非小细胞肺癌的临床分析
3.Clinical Study of Octreotide for Advanced Hepatocellular carcinoma;奥曲肽治疗晚期肝细胞癌的临床观察
6)Late[英][le?t][美][let]晚期
1.Clinical Analysis of 18 Cases withLate Carcinoma of Colon Treated with Xeloda;希罗达治疗晚期结肠癌18例临床分析
2.Preoperative and postoperative nursing of patient with late thyroid carcinoma;晚期甲状腺癌患者手术前后的护理
延伸阅读
拱手跪坐玉人(春秋晚期)高２．５厘米１９７９年出土，现藏河南省文物研究所，殷商以后的跪坐玉人多有发现，拱手状始见于此。
